BACKGROUND: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. OBJECTIVE: To determine the prevalence and severity of HCV infection in asymptomatic persons. DESIGN: Population-based cross-sectional study. SETTING: Northeastern Italy. PATIENTS: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. MEASUREMENTS: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). RESULTS: 116 persons (2.4% [95% CI, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [CI, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (CI, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (CI, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). CONCLUSIONS: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.
BACKGROUND: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. OBJECTIVE: To determine the prevalence and severity of HCV infection in asymptomatic persons. DESIGN: Population-based cross-sectional study. SETTING: Northeastern Italy. PATIENTS: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. MEASUREMENTS: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). RESULTS: 116 persons (2.4% [95% CI, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [CI, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (CI, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (CI, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). CONCLUSIONS: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.
Authors: Gregory D Kirk; Shruti H Mehta; Jacquie Astemborski; Noya Galai; Jonathan Washington; Yvonne Higgins; Ashwin Balagopal; David L Thomas Journal: Ann Intern Med Date: 2013-05-07 Impact factor: 25.391
Authors: Takeki Uehara; Oksana Kosyk; Emmanuelle Jeannot; Blair U Bradford; Katherine Tech; Jeffrey M Macdonald; Gary A Boorman; Saurabh Chatterjee; Ronald P Mason; Stepan B Melnyk; Volodymyr P Tryndyak; Igor P Pogribny; Ivan Rusyn Journal: Toxicol Appl Pharmacol Date: 2012-11-29 Impact factor: 4.219